(1)

Pfizer Ltd has submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisations as regards Commission Regulations (EC) No 2380/2001 (2), (EC) No 1289/2004 (3), (EC) No 1455/2004 (4), (EC) No 1800/2004 (5), (EC) No 600/2005 (6), (EU) No 874/2010 (7), Commission Implementing Regulations (EU) No 388/2011 (8), (EU) No 532/2011 (9) and (EU) No 900/2011 (10).

(2)

The applicant claims that, as a result of Pfizer Ltd’s decision to make its Animal Health Division a stand-alone company under the name of Zoetis Belgium SA and transfer all the marketing authorisations for coccidiostats from Pfizer Ltd to Zoetis Belgium SA, the latter owns the marketing rights for the additives decoquinate, lasalocid A sodium, maduramicin ammonium alpha, robenidine hydrochloride and salinomycin.

(3)

The proposed change of the terms of the authorisations is purely administrative in nature and does not entail a new assessment of the additives concerned. The European Food Safety Authority was informed of the application.

(4)

To allow the applicant to exploit its marketing rights under the name of Zoetis Belgium SA it is necessary to change the terms of the respective authorisations.

(5)

Regulations (EC) No 2380/2001, (EC) No 1289/2004, (EC) No 1455/2004, (EC) No 1800/2004, (EC) No 600/2005, (EU) No 874/2010, and Implementing Regulations (EU) No 388/2011, (EU) No 532/2011 and (EU) No 900/2011 should therefore be amended accordingly.

(6)

Since the modifications to the terms of the authorisations are not related to safety reasons, it is appropriate to provide for a transitional period during which existing stocks may be used up.

(7)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(a)

in the title, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Zoetis Belgium SA’;

(b)

in the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.

(a)

in the title, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Zoetis Belgium SA’;

(b)

in the second column of the Annex, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.

(a)

in the title, the words ‘Alpharma Belgium BVBA’ are replaced by ‘Zoetis Belgium SA’;

(b)

in the second column of Annex I, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’;

(a)

in the title, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Zoetis Belgium SA’;

(b)

in the second column of the Annex to Regulation (EU) No 900/2011, the words ‘Pfizer Ltd’ are replaced by ‘Zoetis Belgium SA’.